Imcore s.r.o.
- Address
- Slovenska 86, 080 01 Prešov, Slovakia
Imcore s.r.o. - Cardiovascular Disease Research Center
Imcore s.r.o. is a clinical research center specializing in cardiovascular disease investigation, with particular emphasis on atherosclerotic cardiovascular disease (ASCVD) and lipid management strategies. The center focuses on evaluating innovative therapeutic approaches for patients with established vascular disease who remain at high risk for cardiovascular events.
- Prevention of major adverse cardiovascular events (MACE) in high-risk populations
- LDL-cholesterol lowering therapies and cardiovascular risk reduction
- Secondary prevention strategies in patients with established atherosclerotic disease
The research center conducts pivotal trials examining novel interventions aimed at reducing the risk of cardiovascular death, myocardial infarction, and ischemic stroke in patients with elevated cholesterol levels despite existing vascular disease. Through participation in large-scale international studies, Imcore s.r.o. contributes to advancing evidence-based treatments for patients requiring intensive cardiovascular risk management and lipid control.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Imcore s.r.o.
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Inclisiran in Reducing Major Adverse Cardiovascular Events in High-Risk Primary Prevention of Atherosclerotic Cardiovascular Disease | Novartis Pharma AG | Phase III | Not Recruiting | Sep 2023 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Inclisiran | 3 | Unknown | 2021-11-26 | 2023-09-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.